Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2020 | 4 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT.
J Nucl Med. 2021 Oct;62(10):1415-1421. doi: 10.2967/jnumed.120.257279. Epub 2021 Feb 12.
J Nucl Med. 2021.
PMID: 33579803
Free article.
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement.
Steinhardt MJ, Krummenast FC, Rosenwald A, Gerhard-Hartmann E, Heidemeier A, Einsele H, Topp MS, Duell J.
Steinhardt MJ, et al. Among authors: krummenast fc.
J Cancer Res Clin Oncol. 2022 Jan;148(1):205-214. doi: 10.1007/s00432-021-03663-x. Epub 2021 Jun 3.
J Cancer Res Clin Oncol. 2022.
PMID: 34085097
Free PMC article.
Item in Clipboard
Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab ("Pom-PAD-Dara") in relapsed/refractory multiple myeloma.
Zhou X, Steinhardt MJ, Grathwohl D, Meckel K, Nickel K, Leicht HB, Krummenast F, Einsele H, Rasche L, Kortüm KM.
Zhou X, et al. Among authors: krummenast f.
Cancer Med. 2020 Aug;9(16):5819-5826. doi: 10.1002/cam4.3209. Epub 2020 Jul 1.
Cancer Med. 2020.
PMID: 32608149
Free PMC article.
Item in Clipboard
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease.
Zhou X, Flüchter P, Nickel K, Meckel K, Messerschmidt J, Böckle D, Knorz S, Steinhardt MJ, Krummenast F, Danhof S, Einsele H, Kortüm KM, Rasche L.
Zhou X, et al. Among authors: krummenast f.
Cancers (Basel). 2020 Apr 23;12(4):1035. doi: 10.3390/cancers12041035.
Cancers (Basel). 2020.
PMID: 32340174
Free PMC article.
Item in Clipboard
The impact of pyrvinium pamoate on colon cancer cell viability.
Wiegering A, Uthe FW, Hüttenrauch M, Mühling B, Linnebacher M, Krummenast F, Germer CT, Thalheimer A, Otto C.
Wiegering A, et al. Among authors: krummenast f.
Int J Colorectal Dis. 2014 Oct;29(10):1189-98. doi: 10.1007/s00384-014-1975-y. Epub 2014 Jul 26.
Int J Colorectal Dis. 2014.
PMID: 25060218
Item in Clipboard
Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma.
Steinhardt MJ, Zhou X, Krummenast F, Meckel K, Nickel K, Böckle D, Messerschmidt J, Knorz S, Dierks A, Heidemeier A, Lapa C, Einsele H, Rasche L, Kortüm KM.
Steinhardt MJ, et al. Among authors: krummenast f.
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420980258. doi: 10.1177/2058738420980258.
Int J Immunopathol Pharmacol. 2020.
PMID: 33353443
Free PMC article.
Item in Clipboard
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib-resistant non-nodal leukemic mantle cell lymphoma.
Zhou X, Steinhardt MJ, Düll J, Krummenast F, Danhof S, Meckel K, Nickel K, Grathwohl D, Leicht HB, Rosenwald A, Einsele H, Rasche L, Kortüm M.
Zhou X, et al. Among authors: krummenast f.
Eur J Haematol. 2020 Apr;104(4):352-355. doi: 10.1111/ejh.13382. Epub 2020 Jan 21.
Eur J Haematol. 2020.
PMID: 31922303
Item in Clipboard
Cite
Cite